Sharon M. Kelly

15.9k citations

234 papers · 12.5k indexed · 3 hit papers · h-index 49

Molecular Biology top 0.5%
- Protein Structure and Dynamics 26
- Photosynthetic Processes and Mechanisms 16
Electronic, Optical and Magnetic Materials top 2%
Biomaterials top 1%
Biotechnology top 1%
Epidemiology top 1%
- Substance Abuse Treatment and Outcomes 42
- HIV, Drug Use, Sexual Risk 12
Materials Chemistry
- Enzyme Structure and Function 41
Public Health, Environmental and Occupational Health
- Opioid Use Disorder Treatment 37
Pediatrics, Perinatology and Child Health
- Prenatal Substance Exposure Effects 24
Genetics
- Bacterial Genetics and Biotechnology 13

Co-authors: Nicholas C. Price Thomas J. Jess Robert P. Schwartz Kevin E. O’Grady Shannon Gwin Mitchell Barry S. Brown Malcolm Kadodwala Nikolaj Gadegaard
Cited by: Molecular Biology Electronic, Optical and Magnetic Materials Biomaterials
Journals: Science (1 paper)Nucleic Acids Research (2 papers)Journal of Biological Chemistry (17 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Sharon M. Kelly

228 papers receiving 12.3k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2010 Nature Nanotechnology
2005 Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
2000 Current Protein and Peptide Science

Peers

Countries citing papers authored by Sharon M. Kelly

Since Specialization

Citations

This map shows the geographic impact of Sharon M. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon M. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon M. Kelly more than expected).

Fields of papers citing papers by Sharon M. Kelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon M. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon M. Kelly. The network helps show where Sharon M. Kelly may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sharon M. Kelly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sharon M. Kelly Line = papers co-authored together Sharon M. Kelly links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial Addiction Science & Clinical Practice ·Courtney Nordeck,Sharon M. Kelly,Robert P. Schwartz,Shannon Gwin Mitchell,Christopher Welsh,Kevin E. O’Grady,Jan Gryczynski	2024	0
2	Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomes International Journal of Drug Policy ·Oluwaseun Falade‐Nwulia,Tracy Agee,Sharon M. Kelly,Ju Nyeong Park,Sheree Schwartz,J. M. Hsu,Nicholas Schweizer,Joyce Jones,Jeanne Keruly,Nishant R. Shah,Catherine R. Lesko,Gregory M. Lucas,Mark Sulkowski	2023	5
3	Identification of diverse lipid‐binding modes in the groove of zinc α ₂ glycoprotein reveals its functional versatility FEBS Journal ·Henna Zahid,Andy M. Lau,Sharon M. Kelly,Kersti Karu,Jayesh Gor,Stephen J. Perkins,Lindsay McDermott	2021	2
4	Combining the platinum(ii) drug candidate kiteplatin with 1,10-phenanthroline analogues Dalton Transactions ·Benjamin J. Pages,Jennette A. Sakoff,Jayne Gilbert,Yingjie Zhang,Sharon M. Kelly,James D. Hoeschele,Janice R. Aldrich‐Wright	2017	7
5	The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings Contemporary Clinical Trials ·Redonna K. Chandler,Matthew S. Finger,David Farabee,Robert P. Schwartz,Timothy P. Condon,Laura J. Dunlap,Gary A. Zarkin,Kathryn E. McCollister,Ryan McDonald,Eugene Laska,David S. Bennett,Sharon M. Kelly,Maureen Hillhouse,Shannon Gwin Mitchell,Kevin E. O’Grady,Joshua D. Lee	2016	16
6	Discovery of a Single Monooxygenase that Catalyzes Carbamate Formation and Ring Contraction in the Biosynthesis of the Legonmycins Angewandte Chemie International Edition ·Sheng Huang,Jioji N. Tabudravu,Somayah S. Elsayed,Jeanne Travert,Doe Peace,Ming Tong,Kwaku Kyeremeh,Sharon M. Kelly,Laurent Trembleau,Rainer Ebel,Marcel Jaspars,Yi Yu,Hai Deng	2015	45
7	Characterisation of the LH2 spectral variants produced by the photosynthetic purple sulphur bacterium Allochromatium vinosum Biochimica et Biophysica Acta (BBA) - Bioenergetics ·Anne‐Marie Carey,Kirsty Hacking,Nichola Picken,Suvi Honkanen,Sharon M. Kelly,Dariusz M. Niedzwiedzki,Robert E. Blankenship,Yuuki Shimizu,Zheng‐Yu Wang‐Otomo,Richard J. Cogdell	2014	31
8	Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status Journal of Drug Issues ·Shannon Gwin Mitchell,Jan Gryczynski,Sharon M. Kelly,Kevin E. O’Grady,Jerome H. Jaffe,Yngvild Olsen,Robert P. Schwartz	2013	11
9	Plant UVR8 Photoreceptor Senses UV-B by Tryptophan-Mediated Disruption of Cross-Dimer Salt Bridges Science ·John M. Christie,A.S. Arvai,Katherine J. Baxter,Monika Heilmann,Ashley J. Pratt,Andrew O’Hara,Sharon M. Kelly,Michael Hothorn,Brian O. Smith,Kenichi Hitomi,Gareth I. Jenkins,Elizabeth D. Getzoff	2012	350
10	A Comparison of Attitudes Toward Opioid Agonist Treatment among Short-Term Buprenorphine Patients The American Journal of Drug and Alcohol Abuse ·Sharon M. Kelly,Barry S. Brown,Elizabeth C. Katz,Kevin E. O’Grady,Shannon Gwin Mitchell,Stuart D. King,Robert P. Schwartz	2012	22
11	Gender Differences Among In- and Out-of-Treatment Opioid-Addicted Individuals The American Journal of Drug and Alcohol Abuse ·Sharon M. Kelly,Robert P. Schwartz,Kevin E. O’Grady,Shannon Gwin Mitchell,Heather Schacht Reisinger,James A. Peterson,Michael Agar,Barry S. Brown	2009	30
12	Interdomain mobility and conformational stability of type III fibronectin domain pairs control surface adsorption, desorption and unfolding Colloids and Surfaces B Biointerfaces ·Patricia Marques Pereira,Sharon M. Kelly,Paul Gellert,Christopher F. van der Walle	2008	10
13	Igf2: mechanisms of imprinting in the choroid plexus Genetics Research ·Trevelyan R. Menheniott,Marika Charalambous,William M. Bennett,Sharon M. Kelly,G. Dell,Andrew Ward	2004	2
14	An enhancer element at the Igf2/H19 locus drives gene expression in both imprinted and non-imprinted tissues Developmental Biology ·Marika Charalambous,Trevelyan R. Menheniott,William Bennett,Sharon M. Kelly,Ghislaine Dell,Luisa Dandolo,Andrew Ward	2004	37
15	The Jehovah's Witness family, transfusions, and pediatric day surgery International Journal of Pediatric Otorhinolaryngology ·John E. Morrison,Geoffrey A. Lane,Sharon M. Kelly,Sylvan E. Stool	1997	3
16	The application of circular dichroism to studies of protein folding and unfolding Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Sharon M. Kelly,Nicholas C. Price	1997	419
17	Ligand-induced conformational changes in wild-type and mutant yeast pyruvate kinase Protein Engineering Design and Selection ·Richard A. Collins,Sharon M. Kelly,Nicholas C. Price,Linda A. Fothergill‐Gilmore,Hilary Muirhead	1996	8
18	Analysis of the structural stability of the multidomain enzyme flavocytochrome P-450 BM3 Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Andrew W. Munro,J. Gordon Lindsay,John R. Coggins,Sharon M. Kelly,Nicholas C. Price	1996	47
19	Purification and Characterization of the Periplasmic Nickel-Binding Protein NikA of Escherichia coli K12 European Journal of Biochemistry ·Karinne de Pina,Clarisse Navarro,Laura Mcwalter,David H. Boxer,Nicholas C. Price,Sharon M. Kelly,Marie‐Andrée Mandrand‐Berthelot,Long‐Fei Wu	1995	55
20	The aromatic amino acid content of the bacterial chaperone protein groEL (cpn60) Evidence for the presence of a single tryptophan FEBS Letters ·Nicholas C. Price,Sharon M. Kelly,Stephen P. Wood,Arlene auf der Mauer	1991	10

About Sharon M. Kelly

Sharon M. Kelly is a scholar working on Biochemistry, Immunology and Allergy and Molecular Biology, having authored 234 papers that have together received 12.5k indexed citations. Recurring topics across this work include Substance Abuse Treatment and Outcomes (42 papers), Enzyme Structure and Function (41 papers), Opioid Use Disorder Treatment (37 papers), Protein Structure and Dynamics (26 papers), Prenatal Substance Exposure Effects (24 papers), Photosynthetic Processes and Mechanisms (16 papers), Bacterial Genetics and Biotechnology (13 papers) and HIV, Drug Use, Sexual Risk (12 papers). The work is most often cited by research in Molecular Biology (6.3k citations), Electronic, Optical and Magnetic Materials (1.0k citations) and Biomaterials (711 citations). Sharon M. Kelly has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Nicholas C. Price, Thomas J. Jess, Nicholas C. Price, Robert P. Schwartz, Kevin E. O’Grady, Shannon Gwin Mitchell, Barry S. Brown, Malcolm Kadodwala, Nikolaj Gadegaard and E. Hendry. Their work appears in journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact